T1	p 61 114	bestatin of acute nonlymphocytic leukemia in adults .
T2	p 419 456	adult acute nonlymphocytic leukemia (
T3	p 632 659	eligible cases ( bestatin :
T4	p 931 949	15-49 yr age group
T5	p 955 971	the 50-65 yr age
T6	p 1151 1167	elderly patients
T7	i 37 55	chemoimmunotherapy
T8	i 61 69	bestatin
T9	i 121 137	immunomodulating
T10	i 337 359	bestatin immunotherapy
T11	i 380 414	remission maintenance chemotherapy
T12	i 552 560	bestatin
T13	i 587 589	po
T14	o 731 740	remission
T15	o 803 813	survival .
T16	o 826 851	prolongation of remission
T17	o 1114 1122	survival